Malaysian Applied Biology Journal

  • Increase font size
  • Default font size
  • Decrease font size

46_01_24

E-mail Print PDF

Malays. Appl. Biol. (2017) 46(1): 165–170


ENCAPSULATION OF miRNA IN CHITOSAN NANOPARTICLES

AS A CANDIDATE FOR AN ANTI-METASTATIC AGENT

IN CANCER THERAPY

SYAZAIRA ARHAM YAHYA ARIFF1*, KHATIJAH YUSOFF2 and MAS JAFFRI MASARUDIN1

1Department of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences,
Universiti Putra Malaysia, 43400, Serdang Selangor, Malaysia
2Department of Microbiology, Faculty of Biotechnology and Biomolecular Sciences,
Universiti Putra Malaysia, 43400, Serdang Selangor, Malaysia

*Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Accepted 27 January 2017, Published online 31 March 2017

 

ABSTRACT

MicroRNAs (miRNA) have been utilised as a repressor molecule for metastasis of tumours, as it inhibits fundamental processes related to cellular and physiological pathway of the tumour at the mRNA level. However, therapeutic application of miRNAs is impaired by premature degradation in the extracellular environment by endonucleases. This research describes the optimisation, chemical, and morphological characterisation of nanoparticles for effective encapsulation of miRNA-186 and evaluate its efficiency as anti-metastatic agent in non-small cell lung carcinoma monolayer. Through ionic gelation methods, the miRNA was encapsulated in chitosan nanoparticles (CNPs), a drug carrier with high particle stability, low cellular toxicity, and robust preparation methods. Physiochemical and morphological characterization analysis through light scattering analysis showed miRNA-CNP sizes below 200 nm, with a low polydispersity index and exhibition of irregular spherical shape of the nanoparticles synthesised through FESEM analysis. Additionally, in vitro nanoparticle efficacy evaluated through scratch assay suggests a decrease in invasion ability of cancer cells exhibited by miRNA-CNP.

Key words: Chitosan nanoparticles, miRNA-186, anti-metastatic agent, cancer therapy

 

Latest MABJ issue

Vol 46(1) March 2017

Table of content

Latest news!

According to MyCite 2014 report, MABJ ranked 95 out of 142 Malaysian journals in terms of yearly impact factor.